EBIT at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's EBIT?
- Viking Therapeutics (VKTX) reported EBIT of -$164.13M in Q1 2026.
- How has Viking Therapeutics's EBIT changed year-over-year?
- Viking Therapeutics's EBIT decreased by 195.9% year-over-year, from -$55.47M to -$164.13M.
- What is the long-term trend for Viking Therapeutics's EBIT?
- Over 4 years (2021 to 2025), Viking Therapeutics's EBIT has grown at a 63.0% compound annual growth rate (CAGR), from -$55.68M to -$393.34M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.